MRK logo Merck & Co. +
Merck & Co.
+

Merck & Co. Overview

Company: Merck & Co.
CEO: Robert Davis
Founded: Jan 1, 1891
Symbol: MRK
Exchange: NYSE
Industry: Drug Manufacturers - General
Sector: Healthcare
About

Merck & Co. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences to jointly develop and commercialize long-acting treatments in HIV. Merck & Co. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Continue reading...

Merck & Co. (MRK)

  • Stock Price
  • Volume
118.72 +47.03 +65.60%
Past 5 Years
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • 10Y
  • ALL

Revenue

Merck & Co. annual revenue was $65.01 B in 2025.

Net Income

Merck & Co. annual net income was $18.25 B in 2025.

Employees

Merck & Co. annual employee count was 75,000 in 2025.

Revenue by Segment

Merck & Co.’s revenue by segment: Animal Health segment: $6.35 B, Other Segments: $515.00 M and Pharmaceutical segment: $58.14 B in 2025.

Revenue by Region

Merck & Co.’s revenue by region: Asia Pacific: $2.98 B, CHINA: $1.94 B, EMEA: $14.58 B, International: $2.88 B, JAPAN: $2.71 B, Latin America: $3.41 B and UNITED STATES: $36.51 B in 2025.

Executive Salary

Robert M. Davis Chairman, Chief Executive Officer and President, at ...

Revenue per Employee

Merck & Co. revenue per employee was $866.81 K in 2025.

Profit per Employee

Merck & Co. profit per employee was $243.39 K in 2025.

Income Statement

Operating Income

Merck & Co. annual operating income was $26.78 B in 2025.

Research & Development

Merck & Co. annual research & development expense was $15.60 B in 2025.

Tax Rate (%)

Merck & Co. annual Tax Rate was 13.00% in 2025.

Assets & Liabilities | Cash Flow

Total Assets

Merck & Co. annual total assets was - in 2025.

Total Liabilities

Merck & Co. annual total liabilities was -$51.91 B in 2025.

Capital Expenditure

Merck & Co. annual capital expenditures was - in 2025.

Ratios

Return on Equity (ROE)

Merck & Co. annual return on equity(ROE) was 35.17% in 2025.

Return on Assets (ROA)

Merck & Co. annual return on assets(ROA) was 0.00% in 2025.

Debt to Equity

Merck & Co. annual debt to equity was 96.06% in 2025.

Profitability

Gross Profit Margin (%)

Merck & Co. annual gross profit margin was 81.50% in 2025.

Operating Income Margin (%)

Merck & Co. annual operating income margin was 41.19% in 2025.

Net Income Margin (%)

Merck & Co. annual net income margin was 28.12% in 2025.

Earning Per Share

Merck & Co. annual earning per share was $7.30 in 2025.

EBITDA

Merck & Co. annual EBITDA was $25.36 B in 2025.

Free Cash Flow (FCF)

Merck & Co. annual free cash flow(FCF) was - in 2025.

Valuation

Enterprise value

Merck & Co. annual enterprise value was $263.93 B in 2025.

Enterprise value to Revenue

Merck & Co. annual enterprise value to revenue was 4.06 in 2025.

Enterprise value to EBITDA

Merck & Co. annual enterprise value to EBITDA was 12.53 in 2025.

Competitors’ Revenue

Frequently Asked Questions

When was Merck & Co. founded?

Merck & Co. was founded on Jan 1, 1891, which makes the company 135 years old.

Sign up for free to view

Who is the CEO of Merck & Co.?

Robert Davis is the CEO of Merck & Co..

What industry and sector is Merck & Co. in?

Merck & Co. operates in the Drug Manufacturers - General industry and the Healthcare sector.

What are Merck & Co.'s CIK, SIC, and ISIN codes?

  • CIK (Central Index Key): 0000310158
  • SIC (Standard Industrial Classification): 2834
  • ISIN (International Securities Identification Number): US58933Y1055

Sign up for free to view

How many employees does Merck & Co. have?

Merck & Co. has 75,000 employees.

What is the revenue of Merck & Co.?

In fiscal year 2025, Merck & Co. generated a revenue of $65.01 Billion.

What is the net income of Merck & Co.?

In fiscal year 2025, Merck & Co. reported a net income of $18.25 Billion.

What is Merck & Co.'s biggest product segment?

Pharmaceutical segment is Merck & Co.'s biggest product segment, representing 89.43% of its total revenue.

When was Merck & Co. listed on the stock exchange?

Merck & Co. went public on Jan 13, 1978, through its Initial Public Offering (IPO), and it has been 48 years since then.

Sign up for free to view

What is the ticker symbol of Merck & Co., and where is it listed?

Merck & Co.'s ticker symbol is MRK, and the company is listed on the NYSE stock market exchange.

What is Merck & Co.'s current stock price?

Merck & Co.'s current stock price is $118.72 as of May 30, 2026.

What is Merck & Co.'s market capitalization?

As of , Merck & Co.'s market cap is .

What is Merck & Co.'s ranking in the world?

Ranked #5among 2,804 companies based on market cap.

Who are the top competitors of Merck & Co.?

Competitors of Merck & Co. include Eli Lilly and Company, Johnson & Johnson and AbbVie, and more.

Related company

Submit feedback to Bullfincher